Meulenbroek, Olga ;
O'Dwyer, Sarah ;
De Jong, Daan...
Meulenbroek , O , O'Dwyer , S , De Jong , D , Van Spijker , G , Kennelly , S , Cregg , F , Rikkert , M O , Abdullah , L , Wallin , A , Walsh , C , Coen , R , Kenny , R A , Daly , L , Segurado , R , Borjesson-Hanson , A , Crawford , F , Mullan , M , Lucca , U , Banzi , R , Pasquier , F , Breuilh , L , Riepe , M , Kalman , J , Molloy , W , Tsolaki , M , Howard , R , Jessica Adams , M O , Gaynor , S & Lawlor , B 2016 , ' European multicentre double-blind placebo-controlled trial of Nilvadipine in mild-to-moderate Alzheimer's disease - The substudy protocols : NILVAD frailty; NILVAD blood and genetic biomarkers; NILVAD cerebrospinal fluid biomarkers; NILVAD cerebral blood flow ' , BMJ Open , vol. 6 , no. 7 , e011584 . https://doi.org/10.1136/bmjopen-2016-011584.
,
2016